Advances 1n the Treatment of
Patients with Benign Brain Tumors*
}-IAROLD F . YOUNG, M.D.

Associate Professor of Neurosurgery, Medical College of Virginia,
Health Sciences Division of Virginia Commonwealth University, Richmond

Introduction. Since the Stoneburner Lecturer for
this year, Dr. Thomas Langfitt, is Professor and
Chairman at the hospital of the University of Pennsylvania, it would only be proper to recall at least one
of the important lessons taught by Dr. Francis Grant,
Dr. Langfitt's predecessor at the University of Pennsylvania. One of Dr. Grant's most remembered dictums was that when a benign brain tumor is encountered, the best surgical team the clinic can
assemble should be put to work on it (I). This is a
valuable concept in the treatment of benign brain
tumors. It is of paramount importance to protect the
brain, to preserve neurological function, to restore
neurological function which has been lost, and to
remove the tumor completely if possible. Ample
statistics reveal a 20% recurrence rate in operated
benign central nervous system tumors, a rate largely
related to incomplete removal at the first operation
(2).
What are the recent advances which will ensure a
better fate for the brain tumor patient? First is the
diagnosis of the degree, if any, of increased intracranial pressure (ICP) before surgery; second is the
meticulous management of anesthesia at surgery; and
third is the use of the operating microscope with the
associated microneurosurgical instrumentation to
provide magnification surgery.
Intracranial Pressure. The recognition of increased intracranial pressure is important not only in
benign brain tumors but all brain tumors which
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manifest increased intracranial pressure by headache,
altered states of consciousness, and the finding of
papilledema. All brain tumor patients treated at
MCY have ICP monitoring for three-to-five days
before surgery, during surgery, and for at least three
days following surgery with a subarachnoid screw (3).
Figure I is a recording of intracranial pressure
demonstrating increased intracranial pressure as the
patient is being monitored before and during steroid
treatment prior to surgery.
If the baseline ICP is elevated above 40 mm Hg
(normal less than 11 mm Hg), there will usually be
plateau waves-a transient marked increase in ICP
up to 60 Hg. With the rise in ICP or at the time of a
plateau wave, there may be a decrease in the level of
consciousness, hypoventilation, and an increase in Paco .
The patient may then be aroused by severe headache;,
or by an examiner, and may then hyperventilate,
lowering the Paco , relieving the headache, and returning intracrani~I pressure to the baseline.
We have found, upon establishing the baseline
ICP, that there is usually no rapid reduction of ICP in
the first 24 hours of steroid therapy even though
clinical improvement is seen during the same period.
We have often observed a decrease in the number of
plateau or Lundberg waves occurring in the first
24-36 hours of steroid treatment. Early clinical improvement in the patient's condition, not associated
with a lowering of mean ICP, may reflect a direct
effect of steroids on the brain or improvement in
cerebral blood flow as brain edema is reduced.
Because ICP is usually reduced only after at least
24-36 hours of steroids, all of our patients are
prepar,ed for brain tumor surgery with three-to-five
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days of steroids. During this long period of time, in
which steroids may be necessary to reduce ICP, effect
membrane stabilization and capillary integrity, they
also may have a beneficial effect on other subcellular
organelles such as lysosomes, which appear better
preserved when the patient has been well prepared
with steroids. Without steroids, under stress of
trauma, breakdown of lysosomes results in formation
of lipofuscin bodies and the release not only of acid
phosphatases, but of other hydrolytic enzymes as well
(4). Experimental evidence also reveals a decrease in
the severity of the traumatized brain when treated
with steroids (5); thus, we use ICP monitoring and
long-term steroid administration prior to surgery to
reduce ICP and to protect the brain from any trauma
that may occur during surgery.
Anesthesia. The next important aspect of the
management of patients with benign brain tumors is
induction of anesthesia. This is a most critical time
for the patient. Even preoperative sedation can cause
hypoventilation, blood gas changes, and alterations
in intracranial pressure between the time the patient
leaves the floor and the time he arrives in the
operating room. All brain tumor patients undergoing
surgery have intracranial pressure subarachnoid
monitoring not only preoperatively but during the
induction of anesthesia as well. Likewise, an arterial
line from the patient's radial artery is connected to a
4 channel Grass recorder, and end-expiratory C0 2 is
measured on a capnograph. By this technique we
have been able to confirm that there are many times
during the induction of anesthesia when a change in
ICP may occur (6). A rise in ICP may be hazardous
for the patient if increased intracranial pressure is
present at the induction of anesthesia. It is best to
have knowledge of the intracranial pressure prior to
the induction of anesthesia as hyperventilation or intravenous mannitol may be needed to reduce intracranial pressure. For instance, while halothane is
not a dangerous anesthetic, increasing its concentration quickly increases intracranial pressure. Figure 2
shows the reduction of ICP when intravenous pentothal is administered. This is in agreement with
Shapiro's recent report showing that thiopental
sodium, or pentobarbital, will reduce intracranial
pressure (7). Ethane is an agent useful in lowering intracranial pressure unless increased to a concentration of 4% or more. lntracranial pressure monitoring
reveals a balanced barbiturate anesthetic to be a
valuable anesthetic technique in brain tumor surgery.
At the time of intubation, there is usually a brief
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Fig. 1-lntracranial pressure recording in mm Hg during 5 days of
steroid (Decadron® 4 mg l m q6h) treatment. On day I and 2
baseline ICP runs between 30-40 mm Hg with plateau waves up to
60 mm Hg. Plateau waves disappear on day 3 but baseline ICP is
only in normal range on the fifth day of treatment.

increase in intracranial pressure associated with a
small change in arterial blood pressure (Fig. 2). A
short period of straining on the endotracheal tube
will likewise produce a rise in ICP, and prolonged
straining or "bucking" must not be allowed.
After the induction of anesthesia, the surgeon
must carefully position the patient's head for his surgical advantage without turning the head so severely
that a major blood vessel to or from the head is
occluded; this is often overlooked in preparing the
patient for surgery. Care must be taken not to
obstruct venous drainage from the head as this will
certainly increase ICP.
INTRACRANIAL PRESSURE AND BLOOD PRESSURE
CHANGES AT ANESTHESIA INDUCTION
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Fig. 2-(Top Tracing) Pentothal lowering ICP within I minute of
administration ; 50 mg pentothal produced a slight decrease in ICP
while 350 mg produced a marked decrease in ICP. (Bottom Tracing) Rise in ICP to almost 60 mm Hg during intubation.
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Following the induction, both the surgeon and
the anesthesiologist must also focus on ventilation of
the patient. Figure 3 is the ICP recording of an operation on the posterior fossa where spontaneous
respiration is generally used since it is a safeguard
against undue trauma or traction of the br;iinstem .
Spontaneous respiration produced a prompt rise in
intracranial pressure and the patient was then placed
on a respirator to control ventilation and reduce ICP.
In order to operate on an ;idult patient, intracranial
pressure is maintained in a safe range with ventilation
controlled at the rate of 12 respirations/ min and a
tidal volume of 900 cc with each respiration . Unfortunately, when the surgeon is operating he may ,
nevertheless, reach a point where he is about to open
the dura only to find it very tight. If the surgeon
demands that the anestheti st hyperventilate the
patient, an over reaction by the anesthetist of rapid
hand ventilation may result in exchange of a small
tidal volume too rapidly for sufficient venous return
and intracranial pressure may not be lowered but
may actually be increased . The induction of
anesthesia must be attended by the neurosurgeon as
well as the anesthetist. This is one of the most important aspects of the operation, errors in management
of the anesthetic resulting in intracranial pressure
changes could lead to a tragic result from the operation.
Magnification Surgery. One of the reasons for
emphasizing control of intracranial pressure and the
induction of anesthesia is that it is important, in the
technique of operating on a brain tumor using an
operating microscope, to have as much exposure as
possible often beneath the brain or deep within the
SPONTANEOUS AND ASSISTED
VENTILATION IN SURGERY
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Fig. 3-lntracranial pressure recording during posterior fossa surgery demonstrating repeated elevation of ICP whenever the patient
is allowed to breath spontaneously. This elevation of ICP is corrected by assisting respiration (Top Tracing).

Fig. 4-Ceiling-mounted operating microscope in the
neurosurgical operating room at the Medical College of Virginia.
Focusing is accomplished by foot control pedal not shown in
figure.

brain without retracting the brain . Careful attention
to the small metabolic parameters discussed above
;ifford a much better opportunity to operate on the
brain under relaxed conditions. Brain retractors
should be used to protect the brain, not to retract the
brain, and the tumor must be removed from the
brain, not the brain from the tumor. The operating
microscope has changed our approach not only to intracranial vascular surgery, where it is absolutely
necessary, but also to benign brain tumor surgery as
well. Presently the only type of tumors not requiring
use of a microscope are malignant gliomas of the
cerebral hemispheres.
At MCV a ceiling-mounted microscope allows
the surgeon and one assistant or resident to see and
become involved in the operation (Fig. 4). The best
place to install a ceiling-mounted microscope is in the
center of the operating room. Many surgeons prefer
the floor-mounted movable microscope, finding it
easier to move the microscope to the patient than to
move the patient to the fixed microscope. The
limitations of the microscope earlier in our ex-
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perience included the fact that it made resident
teaching difficult and did not allow the scrub nurse or
the anesthesiologist the opportunity to view the surgery. A video tape camera can be attached to the
operating microscope allowing both the scrub nurse
and the anesthesiologist to view the surgery and also
the televising of the surgery to any location in the
hospital, providing greater flexibility of the microscope as a teaching instrument.
The important lessons in developing excellent
microsurgery techniques are learned in the
microneurosurgical laboratory. An extended period
of time must be spent in the laboratory learning how
to handle and drape the microscope as well as to
learn microneurosurgical instrumentation and
techniques. The MCV division of Neurosurgery has
such a laboratory, One should borrow neither the
ophthalmologists' nor the otolaryngologists' microscope for an occasional neurosurgical operation
nor purchase a set of a famous neurosurgeon's instruments and expect to immediately perform magnification neurosurgery.
With the proper use of the microscope, it is
possible to approach any area in or near the brain to
safely remove tumors while preserving vital structure.
For instance, the microscope has been the primary
reason for the renewed interest in the transsphenoidal
approach to pituitary surgery. The small secreting
tumors of the pituitary causing acromegaly can now
be removed while preserving the pituitary gland (8).
Summary. Reliable ICP measurement allows an
exact quantitation and management of intracranial
pressure. This precise assessment of ICP is a valuable
adjunct in the management of a nesthesia for brain
tumor patients. The proper combination of ICP and
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anesthesia management enables the surgeon to use
the operating microscope to approach previously inaccessible areas of the brain and to perform
meticulous surgery with a better prognosis for the
brain tumor patient.
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